Vera Therapeutics Submits Biologics License Application to U.S. FDA through Accelerated Approval Program for Atacicept for the Treatment of Adults with IgA Nephropathy
Atacicept received FDA Breakthrough Therapy Designation for the treatment of IgANORIGIN Phase…
FPT Empowers Developers to Fast-Track AI Innovation with AI Notebook Running On NVIDIA Accelerated Computing
HANOI, Vietnam, Nov. 5, 2025 /PRNewswire/ -- FPT, a global ICT corporation…
Fermenta Announces Granting of CEP by EDQM for VITADEE 100 SD, Enabling Accelerated Global Growth
THANE, India, July 30, 2025 /PRNewswire/ -- Fermenta Biotech Limited ("Fermenta"), a pioneer…
